The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 1727520)

Published in JAMA on January 08, 1992

Authors

R W Evans1, C E Orians, N L Ascher

Author Affiliations

1: Battelle-Seattle Research Center, WA 98105.

Articles citing this

Racial differences in access to kidney transplantation. Health Care Financ Rev (1995) 1.93

What will increase the number of organs for transplantation? Some strategies to consider. CMAJ (1994) 1.39

Effect of donor age and sex on the outcome of liver transplantation. Hepatology (1995) 1.31

Potential organ-donor supply and efficiency of organ procurement organizations. Health Care Financ Rev (2003) 0.91

Using a standardized donor ratio to assess the performance of organ procurement organizations. Health Serv Res (2002) 0.90

Benchmarking organ procurement organizations: a national study. Health Serv Res (1999) 0.83

An exploratory study of relational, persuasive, and nonverbal communication in requests for tissue donation. J Health Commun (2011) 0.83

Comparative analysis of heart functions in micropigs and conventional pigs using echocardiography and radiography. J Vet Sci (2007) 0.82

Ventricular assist devices as a bridge to cardiac transplantation. A prelude to destination therapy. Ann Surg (1997) 0.82

CT perfusion technique for assessment of early kidney allograft dysfunction: preliminary results. Eur Radiol (2013) 0.81

A method for estimating solid organ donor potential by organ procurement region. Am J Public Health (1998) 0.81

Physicians' Belief about Organ Donation. Int J Organ Transplant Med (2011) 0.79

Genetic modification of xenografts. Curr Top Microbiol Immunol (2003) 0.77

The Batista procedure: fact, fiction and its role in the management of heart failure. Heart Fail Rev (2001) 0.77

Long term follow up of severely ill patients who underwent urgent cardiac transplantation. BMJ (1993) 0.77

The future of organ replacement: needs, potential applications, and obstacles to application. Transplant Proc (2006) 0.75

Deceased organ donation for transplantation: Challenges and opportunities. World J Transplant (2016) 0.75

64-channel multi-detector row CT angiographic evaluation of the micropigs for potential living donor lung transplantation. J Vet Sci (2010) 0.75

[Assessment of the need for organ transplantation in Quebec]. CMAJ (1994) 0.75

Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation. J Am Coll Surg (2017) 0.75

Effectiveness of (99m)Tc-tetrofosmin for assessment of heart functions in micropigs. J Vet Sci (2007) 0.75

Articles by these authors

(truncated to the top 100)

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19

"Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet (1994) 3.33

Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50

Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18

Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology (1992) 2.09

Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg (2000) 2.09

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant (2007) 2.00

Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92

Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology (1995) 1.81

Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med (1992) 1.80

Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet (1992) 1.63

A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant (2006) 1.61

Liver transplantation in a patient with protoporphyria. Gastroenterology (1989) 1.60

Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med (1991) 1.58

Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51

Influence of donor age on graft survival after liver transplantation--United Network for Organ Sharing Registry. Liver Transpl Surg (1995) 1.51

The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation (1995) 1.43

Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology (1992) 1.41

A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation (1992) 1.40

United Network for Organ Sharing center-specific data: our report card. Liver Transpl Surg (1996) 1.39

Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation (1993) 1.38

Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology (1994) 1.37

Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol (1987) 1.30

Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg (1990) 1.23

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology (1996) 1.19

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology (1996) 1.17

A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15

100 second renal allografts from a single transplantation institution. Transplantation (1979) 1.14

Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation (1979) 1.14

Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: a clinicopathologic study. Ann Surg (2000) 1.13

Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology (1991) 1.13

Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology (1986) 1.12

Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology (1992) 1.12

Imaging of vascular complications after hepatic transplantation. AJR Am J Roentgenol (1988) 1.08

Physical activity and health-related quality of life in liver transplant recipients. Liver Transpl (2001) 1.07

Radiolabeled autologous leukocyte scanning in abscess detection. World J Surg (1980) 1.06

Hepatic transplantation and biliary atresia: early experience in eight patients. World J Surg (1984) 1.05

Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg (1995) 1.05

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology (1998) 1.05

Indium 111 autologous tagged leukocytes in the diagnosis of intraperitoneal sepsis. Arch Surg (1979) 1.05

FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05

Mass screening in low-income populations: the challenges of securing diagnostic and treatment services in a national cancer screening program. J Health Polit Policy Law (2000) 1.04

Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery (1979) 1.04

Metabolism during hepatic transplantation: indicators of allograft function. Surgery (1984) 1.02

Cyclosporine immunosuppression. Clin Pharm (1984) 1.02

The use of the T tube after orthotopic liver transplantation. Transplantation (1996) 1.01

Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation (1999) 1.00

Use of services by diabetes patients in managed care organizations. Development of a diabetes surveillance system. CDC Diabetes in Managed Care Work Group. Diabetes Care (1998) 0.99

Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience. J Vasc Interv Radiol (1990) 0.99

Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology (1994) 0.98

Liver transplantation for sclerosing cholangitis. Hepatology (1995) 0.98

Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Transplantation (1984) 0.97

Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology (1996) 0.96

Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Transplant Proc (1985) 0.95

Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation (1987) 0.95

Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection. Transplant Proc (1998) 0.95

Tuberculous joint disease in transplant patients. Am J Surg (1978) 0.93

Listeria infection in transplant patients. Five cases and a review of the literature. Arch Surg (1978) 0.92

Hepatitis C in patients undergoing liver transplantation. Ann Intern Med (1991) 0.92

Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg (1996) 0.91

Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation (1993) 0.91

Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients. J Vasc Surg (1992) 0.90

Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc (1991) 0.89

Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation (1998) 0.89

A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants. Transplantation (2000) 0.89

The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation (1986) 0.89

Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg (1995) 0.88

Quo vadis, my transplant fellow: a discussion of transplant surgery fellowship training activity in the United States and Canada: 1991-1997. Education Committee of the American Society of Transplant Surgeons. Transplantation (1998) 0.88

Intragraft cytokine profile during human liver allograft rejection. Transplantation (1992) 0.88

Living related donor liver transplantation: the UCSF experience. Transplant Proc (1996) 0.88

The impact of surgical complications after liver transplantation on resource utilization. Arch Surg (1997) 0.88

Cellular events within the rejecting allograft. Transplantation (1983) 0.88

Liver transplantation. N Engl J Med (1984) 0.87

Failure patterns of cryopreserved vein grafts in liver transplantation. Transplantation (1996) 0.87

Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine. Eur J Clin Pharmacol (1989) 0.87

Nonoperative management of biliary leaks after orthotopic liver transplantation. Transplantation (1993) 0.87

Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets. Transplantation (1991) 0.86

A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival. Transplantation (2000) 0.85

Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Transplant Proc (1986) 0.85

Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Am J Kidney Dis (1985) 0.85

Transplant renal artery stenosis. Transplantation (1989) 0.85

Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes (1993) 0.84

Fifty-percent partial liver transplantation in the rat. Transplantation (1996) 0.84

The management of T tube leaks in orthotopic liver transplant recipients with endoscopically placed nasobiliary catheters. Transplantation (1990) 0.84

Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers. Transplantation (2001) 0.84

Hemodynamic changes on clamping and unclamping of major vessels during liver transplantation. Transplant Proc (1989) 0.84

Liver transplantation for autoimmune hepatitis: rejection and recurrence. Transplant Proc (1999) 0.84

Maturation of cytotoxic effector cells at the site of allograft rejection. Transplant Proc (1981) 0.84

Specific and nonspecific infiltration of sponge matrix allografts by specifically sensitized cytotoxic lymphocytes. Cell Immunol (1980) 0.84

Liver allograft transplantation: postoperative CT findings. AJR Am J Roentgenol (1987) 0.83

Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus. Transplantation (1988) 0.83

A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. Transplantation (1997) 0.83

Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol (1991) 0.83

Anesthetic care of patients with Crigler-Najjar syndrome. Anesth Analg (1992) 0.83

New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation. Transplant Proc (1986) 0.83

Maturation of cytotoxic T cells within sponge matrix allografts. J Immunol (1983) 0.82

Biliary complications of reduced-organ liver transplantation. Liver Transpl Surg (1998) 0.82

The outcome of 304 primary renal transplants in children (1968-1985). Ann Surg (1986) 0.81

Posttransplantation growth in pediatric liver recipients. Liver Transpl (2001) 0.81